Français
ItalianoBond Teva Pharmaceutical Industries 0% ( US88166DAB29 ) in USD
| Issuer | Teva Pharmaceutical Industries | ||||||
| Market price | 100.00 % ⇌ | ||||||
| Country |  Israel
|
||||||
| ISIN code |
 US88166DAB29 ( in USD )
|
||||||
| Interest rate | 0% | ||||||
| Maturity | 21/03/2014 - Bond has expired | ||||||
|
Prospectus brochure in PDF format |
|||||||
| Minimal amount | 2 000 USD | ||||||
| Total amount | 500 000 000 USD | ||||||
| Cusip | 88166DAB2 | ||||||
| Standard & Poor's ( S&P ) rating | NR | ||||||
| Moody's rating | NR | ||||||
| Detailed description |
Teva Pharmaceutical Industries is a global pharmaceutical company specializing in generic and specialty medications, with a focus on central nervous system disorders, respiratory diseases, oncology, and women's health. This fixed-income security, identified by ISIN US88166DAB29 and CUSIP 88166DAB2, was issued by Teva Pharmaceutical Industries, a prominent global pharmaceutical company headquartered in Israel; this USD-denominated bond, part of a $500,000,000 total issuance with a minimum purchase size of $2,000, featured a 0% interest rate and a reported payment frequency of two per year before its maturity on March 21, 2014, at which point it was fully redeemed at its 100% par value, having previously carried 'NR' (Not Rated) designations from both Standard & Poor's and Moody's. |
||||||
| |||||||